Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Factors associated with perceived loss of libido in people who inject opioids: Results from a community-based survey in France.

Briand Madrid L, Morel S, Ndiaye K, Mezaache S, Rojas Castro D, Mora M, Olivet F, Laporte V, Protopopescu C, Carrieri P, Roux P.

Drug Alcohol Depend. 2018 Sep 1;190:121-127. doi: 10.1016/j.drugalcdep.2018.05.030. Epub 2018 Jul 11.

PMID:
30014887
2.

LEC1 (NF-YB9) directly interacts with LEC2 to control gene expression in seed.

Boulard C, Thévenin J, Tranquet O, Laporte V, Lepiniec L, Dubreucq B.

Biochim Biophys Acta Gene Regul Mech. 2018 May;1861(5):443-450. doi: 10.1016/j.bbagrm.2018.03.005. Epub 2018 Mar 24.

PMID:
29580949
3.

Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France.

Roux P, Rojas Castro D, Ndiaye K, Briand Madrid L, Laporte V, Mora M, Maradan G, Morel S, Spire B, Carrieri P.

Subst Abuse Treat Prev Policy. 2017 Nov 2;12(1):46. doi: 10.1186/s13011-017-0131-4.

4.

Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.

Stancu IC, Ris L, Vasconcelos B, Marinangeli C, Goeminne L, Laporte V, Haylani LE, Couturier J, Schakman O, Gailly P, Pierrot N, Kienlen-Campard P, Octave JN, Dewachter I.

FASEB J. 2014 Jun;28(6):2620-31. doi: 10.1096/fj.13-246702. Epub 2014 Mar 6.

PMID:
24604080
5.

Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice.

Héraud C, Goufak D, Ando K, Leroy K, Suain V, Yilmaz Z, De Decker R, Authelet M, Laporte V, Octave JN, Brion JP.

Neurobiol Dis. 2014 Feb;62:100-12. doi: 10.1016/j.nbd.2013.09.010. Epub 2013 Sep 27.

PMID:
24076100
6.

Characterization of three amino-functionalized surfaces and evaluation of antibody immobilization for the multiplex detection of tumor markers involved in colorectal cancer.

Yang Z, Chevolot Y, Géhin T, Dugas V, Xanthopoulos N, Laporte V, Delair T, Ataman-Önal Y, Choquet-Kastylevsky G, Souteyrand E, Laurenceau E.

Langmuir. 2013 Feb 5;29(5):1498-509. doi: 10.1021/la3041055. Epub 2013 Jan 22.

PMID:
23305497
7.

Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice.

Leroy K, Ando K, Laporte V, Dedecker R, Suain V, Authelet M, Héraud C, Pierrot N, Yilmaz Z, Octave JN, Brion JP.

Am J Pathol. 2012 Dec;181(6):1928-40. doi: 10.1016/j.ajpath.2012.08.012. Epub 2012 Sep 28.

PMID:
23026200
8.

Low-temperature preparation of tailored carbon nanostructures in water.

Szilluweit R, Hoheisel TN, Fritzsche M, Ketterer B, Fontcuberta i Morral A, Demurtas D, Laporte V, Verel R, Bolisetty S, Mezzenga R, Frauenrath H.

Nano Lett. 2012 May 9;12(5):2573-8. doi: 10.1021/nl300822f. Epub 2012 Apr 10.

PMID:
22458647
9.

Surface functionalization of alumina ceramic foams with organic ligands.

Comas H, Laporte V, Borcard F, Miéville P, Krauss Juillerat F, Caporini MA, Gonzenbach UT, Juillerat-Jeanneret L, Gerber-Lemaire S.

ACS Appl Mater Interfaces. 2012 Feb;4(2):573-6. doi: 10.1021/am201638a. Epub 2012 Jan 25.

PMID:
22257109
10.

Highly active oxide photocathode for photoelectrochemical water reduction.

Paracchino A, Laporte V, Sivula K, Grätzel M, Thimsen E.

Nat Mater. 2011 Jun;10(6):456-61. doi: 10.1038/nmat3017. Epub 2011 May 8.

PMID:
21552270
11.

Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier.

Paris D, Bachmeier C, Patel N, Quadros A, Volmar CH, Laporte V, Ganey J, Beaulieu-Abdelahad D, Ait-Ghezala G, Crawford F, Mullan MJ.

Mol Med. 2011 Mar-Apr;17(3-4):149-62. doi: 10.2119/molmed.2010.00180. Epub 2010 Dec 17.

12.

Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease.

Paris D, Ganey N, Banasiak M, Laporte V, Patel N, Mullan M, Murphy SF, Yee GT, Bachmeier C, Ganey C, Beaulieu-Abdelahad D, Mathura VS, Brem S, Mullan M.

J Neurosci. 2010 Aug 25;30(34):11251-8. doi: 10.1523/JNEUROSCI.2586-10.2010.

13.

Anti-Tumoral Activity of a Short Decapeptide Fragment of the Alzheimer's Abeta Peptide.

Paris D, Patel N, Ganey NJ, Laporte V, Quadros A, Mullan MJ.

Int J Pept Res Ther. 2010;16(1):23-30.

14.

Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.

Paris D, Ganey NJ, Laporte V, Patel NS, Beaulieu-Abdelahad D, Bachmeier C, March A, Ait-Ghezala G, Mullan MJ.

J Neuroinflammation. 2010 Mar 8;7:17. doi: 10.1186/1742-2094-7-17.

15.

Complement receptor 3 (CD11b/CD18) is implicated in the elimination of β-amyloid peptides.

Choucair-Jaafar N, Laporte V, Levy R, Poindron P, Lombard Y, Gies JP.

Fundam Clin Pharmacol. 2011 Feb;25(1):115-22. doi: 10.1111/j.1472-8206.2010.00811.x.

PMID:
20199584
16.

Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2.

Patel NS, Mathura VS, Bachmeier C, Beaulieu-Abdelahad D, Laporte V, Weeks O, Mullan M, Paris D.

J Neurochem. 2010 Jan;112(1):66-76. doi: 10.1111/j.1471-4159.2009.06426.x. Epub 2009 Oct 10.

17.

Apolipoprotein E-genotype dependent hippocampal and cortical responses to traumatic brain injury.

Crawford F, Wood M, Ferguson S, Mathura V, Gupta P, Humphrey J, Mouzon B, Laporte V, Margenthaler E, O'Steen B, Hayes R, Roses A, Mullan M.

Neuroscience. 2009 Apr 10;159(4):1349-62. doi: 10.1016/j.neuroscience.2009.01.033. Epub 2009 Feb 21.

PMID:
19409232
18.

Novel role of CXCR2 in regulation of gamma-secretase activity.

Bakshi P, Margenthaler E, Laporte V, Crawford F, Mullan M.

ACS Chem Biol. 2008 Dec 19;3(12):777-89. doi: 10.1021/cb800167a.

PMID:
19067586
19.

CD40 ligation mediates plaque-associated tau phosphorylation in beta-amyloid overproducing mice.

Laporte V, Ait-Ghezala G, Volmar CH, Ganey C, Ganey N, Wood M, Mullan M.

Brain Res. 2008 Sep 22;1231:132-42. doi: 10.1016/j.brainres.2008.06.032. Epub 2008 Jun 19.

PMID:
18606155
20.

Potent anti-angiogenic motifs within the Alzheimer beta-amyloid peptide.

Patel NS, Quadros A, Brem S, Wotoczek-Obadia M, Mathura VS, Laporte V, Mullan M, Paris D.

Amyloid. 2008 Mar;15(1):5-19. doi: 10.1080/13506120701814723.

PMID:
18266117
21.

The role of calcium and magnesium ions in uptake of beta-amyloid peptides by microglial cells.

Choucair N, Laporte V, Levy R, Tranchant C, Gies JP, Poindron P, Lombard Y.

Int J Immunopathol Pharmacol. 2006 Jul-Sep;19(3):683-96.

PMID:
17026853
22.

CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models.

Laporte V, Ait-Ghezala G, Volmar CH, Mullan M.

J Neuroinflammation. 2006 Feb 24;3:3.

23.

Comparing reagents for efficient transfection of human primary myoblasts: FuGENE 6, Effectene and ExGen 500.

Arnold AS, Laporte V, Dumont S, Appert-Collin A, Erbacher P, Coupin G, Levy R, Poindron P, Gies JP.

Fundam Clin Pharmacol. 2006 Feb;20(1):81-9.

PMID:
16448398
24.

Genomic regulation after CD40 stimulation in microglia: relevance to Alzheimer's disease.

Ait-Ghezala G, Mathura VS, Laporte V, Quadros A, Paris D, Patel N, Volmar CH, Kolippakkam D, Crawford F, Mullan M.

Brain Res Mol Brain Res. 2005 Oct 31;140(1-2):73-85. Epub 2005 Sep 22.

PMID:
16182406
25.

Anti-angiogenic activity of the mutant Dutch A(beta) peptide on human brain microvascular endothelial cells.

Paris D, Ait-Ghezala G, Mathura VS, Patel N, Quadros A, Laporte V, Mullan M.

Brain Res Mol Brain Res. 2005 May 20;136(1-2):212-30. Epub 2005 Apr 1.

PMID:
15893605
27.

A gradual process of recombination restriction in the evolutionary history of the sex chromosomes in dioecious plants.

Nicolas M, Marais G, Hykelova V, Janousek B, Laporte V, Vyskot B, Mouchiroud D, Negrutiu I, Charlesworth D, Monéger F.

PLoS Biol. 2005 Jan;3(1):e4. Epub 2004 Dec 21.

28.

Uptake of Abeta 1-40- and Abeta 1-42-coated yeast by microglial cells: a role for LRP.

Laporte V, Lombard Y, Levy-Benezra R, Tranchant C, Poindron P, Warter JM.

J Leukoc Biol. 2004 Aug;76(2):451-61. Epub 2004 May 10.

PMID:
15136588
29.
30.

Adult pertussis prevalence.

LaPorte V.

Minn Med. 2002 Apr;85(4):6; author reply 6. No abstract available.

PMID:
11975056
31.

Non-sex-linked, nuclear cleaved amplified polymorphic sequences in Silene latifolia.

Laporte V, Charlesworth D.

J Hered. 2001 Jul-Aug;92(4):357-9.

PMID:
11535652
32.

DNA diversity in sex-linked and autosomal genes of the plant species Silene latifolia and Silene dioica.

Filatov DA, Laporte V, Vitte C, Charlesworth D.

Mol Biol Evol. 2001 Aug;18(8):1442-54.

PMID:
11470835
33.
35.

Safety, tolerability, and pharmacokinetics of SR 49059, a V1a vasopressin receptor antagonist, after repeated oral administration in healthy volunteers.

Brouard R, Laporte V, Serradeil Le Gal C, Pignol R, Jang H, Donat F, Lockwood G, Fournie D, Dreux F.

Adv Exp Med Biol. 1998;449:455-65.

PMID:
10026839
37.

Pharmacokinetic study of ioxaglate, a low osmolality contrast medium, in patients with renal failure.

Bourin M, Laporte V, Guenzet J, Langlois S, Pengloan J, Rouleau P.

Int J Clin Pharmacol Ther Toxicol. 1986 Nov;24(11):614-21.

PMID:
3793295
38.

[Pharmacokinetics in man of adipiodone and radiological results (author's transl)].

Rymer R, Berger N, Laporte V, Menanteau M, May JP.

Ann Radiol (Paris). 1977 Jul-Sep;20(6):603-8. French. No abstract available.

PMID:
921204
39.

Acute pancreatitis in pregnancy with Ascaris infestation.

LaPorte VD, Gibbs RS.

Obstet Gynecol. 1977 Jan;49(1 suppl):84-5.

PMID:
831188

Supplemental Content

Loading ...
Support Center